Apyx Medical (APYX) Total Current Liabilities (2010 - 2026)

Apyx Medical has reported Total Current Liabilities for 17 years, with the latest figure at $9.4 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities fell 0.66% year-over-year to $9.4 million; the trailing twelve-month figure through Mar 2026 stood at $9.4 million (down 0.66% YoY), and the FY2025 full-year result was $11.7 million, up 9.13% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $9.4 million, down from $11.7 million in the prior quarter.
• The five-year high for Total Current Liabilities was $19.0 million in Q2 2023, with the low at $9.4 million in Q1 2026.
• Historically, Total Current Liabilities has averaged $11.8 million across 5 years, with a median of $11.0 million in 2025.
• Annual changes were most pronounced in 2023 — Total Current Liabilities jumped 67.63% — and 2024, when it sank 44.09%.
• Apyx Medical's Total Current Liabilities stood at $11.8 million in 2022, then gained by 7.51% to $12.7 million in 2023, then decreased by 15.85% to $10.7 million in 2024, then grew by 9.13% to $11.7 million in 2025, then fell by 19.26% to $9.4 million in 2026.
• The last three Total Current Liabilities figures came in at $9.4 million (Q1 2026), $11.7 million (Q4 2025), and $11.0 million (Q3 2025), per Business Quant data.